Charles River Associates (Life Sciences)
Overview
Publicly traded economic and management consulting firm whose life sciences practice focuses on pricing, market access, HEOR/value framing, and policy analysis. Strong fit for high-value, policy-sensitive categories such as rare disease, oncology, and cell and gene therapy.
Notable
Acquired bioStrategies Group (2022) and C1 Consulting (2017) to expand its life sciences practice.
Key services
- Pricing & market access strategy
- Value & HEOR framing
- Policy & economic analysis
- Commercialization strategy
- Litigation-sensitive strategy
Subcategories
Verified Reviews
No verified reviews yet — are you a customer of Charles River Associates (Life Sciences)? Share your experience in a short, confidential interview.
Share your experience